Cite
HARVARD Citation
Ebata, S. et al. (2017). Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease. Scandinavian journal of rheumatology. pp. 247-252. [Online].